secwatch.observer — SEC 8-K summary
======================================

Issuer:     Glucotrack, Inc. (GCTK)
CIK:        0001506983
Form:       8-K
Filed at:   2026-07-15T21:20:18+00:00
Accession:  0001493152-26-033393
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 1.01, 2.01, 2.03, 3.02, 5.01, 5.02, 5.03, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glucotrack completes reverse merger with Lokahi; existing holders get 10% floor
-------------------------------------------------------------------------------

- Lokahi shareholders receive 90% of fully diluted equity; existing Glucotrack holders get at least 10%.
- CEO Paul Goode resigns; Erik Emerson appointed CEO and board member effective July 14, 2026.
- Bridge financing of $4.45M via senior secured convertible notes and warrants closed same day.
- Subsidiary contribution of $7M to Operating Sub for diabetes business, released in installments.
- Post-closing: proxy statement for stockholder approval and Nasdaq listing of conversion shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506983/000149315226033393/0001493152-26-033393-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506983/000149315226033393/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-033393

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer